IL162432A0 - Deuterated substituted pyrazolylbenzylsulfonamidesand medicaments comprising said compounds - Google Patents

Deuterated substituted pyrazolylbenzylsulfonamidesand medicaments comprising said compounds

Info

Publication number
IL162432A0
IL162432A0 IL16243202A IL16243202A IL162432A0 IL 162432 A0 IL162432 A0 IL 162432A0 IL 16243202 A IL16243202 A IL 16243202A IL 16243202 A IL16243202 A IL 16243202A IL 162432 A0 IL162432 A0 IL 162432A0
Authority
IL
Israel
Prior art keywords
pyrazolylbenzylsulfonamidesand
medicaments
compounds
deuterated substituted
deuterated
Prior art date
Application number
IL16243202A
Other languages
English (en)
Original Assignee
Turicum Drug Dev Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Turicum Drug Dev Ag filed Critical Turicum Drug Dev Ag
Publication of IL162432A0 publication Critical patent/IL162432A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
IL16243202A 2001-12-12 2002-12-11 Deuterated substituted pyrazolylbenzylsulfonamidesand medicaments comprising said compounds IL162432A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10162121A DE10162121A1 (de) 2001-12-12 2001-12-12 Deuterierte substituierte Pyrazolyl-Benzolsulfonamide sowie diese Verbindungen enthaltende Arzneimittel
PCT/DE2002/004600 WO2003050091A1 (de) 2001-12-12 2002-12-11 Deuterierte substituierte pyrazolyl-benzolsulfonamide sowie diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
IL162432A0 true IL162432A0 (en) 2005-11-20

Family

ID=7709640

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16243202A IL162432A0 (en) 2001-12-12 2002-12-11 Deuterated substituted pyrazolylbenzylsulfonamidesand medicaments comprising said compounds

Country Status (14)

Country Link
US (1) US20050222238A1 (xx)
EP (1) EP1456179A1 (xx)
JP (1) JP2005516009A (xx)
CN (1) CN1612863A (xx)
AU (1) AU2002357973A1 (xx)
CA (1) CA2471743A1 (xx)
DE (1) DE10162121A1 (xx)
HU (1) HUP0402422A2 (xx)
IL (1) IL162432A0 (xx)
IS (1) IS7304A (xx)
NO (1) NO20042906L (xx)
PL (1) PL370563A1 (xx)
RU (1) RU2004121033A (xx)
WO (1) WO2003050091A1 (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101268050B (zh) * 2005-07-26 2012-11-28 奈科明有限责任公司 同位素取代的泮托拉唑
US7601737B2 (en) * 2005-07-26 2009-10-13 Nycomed Gmbh Isotopically substituted proton pump inhibitors
CN101268051B (zh) * 2005-07-26 2011-08-31 奈科明有限责任公司 同位素取代的质子泵抑制剂
EP1934201A1 (en) * 2005-10-06 2008-06-25 Auspex Pharmaceuticals Inc. Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties
US20070287734A1 (en) * 2006-06-09 2007-12-13 Auspex Pharmaceuticals, Inc. Preparation and utility of substituted pyrazole compounds with cannabinoid receptor activity
WO2008070619A1 (en) * 2006-12-04 2008-06-12 Auspex Pharmaceuticals, Inc. Deuterated oxazolidinones and their use as antibiotics
JP2010512343A (ja) * 2006-12-08 2010-04-22 オースペックス・ファーマシューティカルズ・インコーポレイテッド 置換アリルアミン類の調製および実用性
US20080299216A1 (en) * 2007-06-01 2008-12-04 Protia, Llc Deuterium-enriched aripiprazole
US20090062364A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched celecoxib
US20090062185A1 (en) * 2007-08-29 2009-03-05 Protia, Llc Deuterium-enriched anidulafungin
US20090209608A1 (en) * 2007-08-29 2009-08-20 Protia, Llc Deuterium-enriched asenapine
US20090069219A1 (en) * 2007-09-09 2009-03-12 Protia, Llc Deuterium-enriched telavancin
US20090076158A1 (en) * 2007-09-13 2009-03-19 Protia, Llc Deuterium-enriched bicalutamide
US20090075870A1 (en) * 2007-09-17 2009-03-19 Protia, Llc Deuterium-enriched caspofungin
US20090082419A1 (en) * 2007-09-26 2009-03-26 Protia, Llc Deuterium-enriched tegaserod
US20100120756A1 (en) * 2008-09-17 2010-05-13 Auspex Pharmaceuticals, Inc. Phenothiazine modulators of h1 receptors
US8227451B2 (en) * 2008-11-12 2012-07-24 Auspex Pharmaceuticals Phenylacetic acid inhibitors of cyclooxygenase
AR075584A1 (es) 2009-02-27 2011-04-20 Intermune Inc COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO.
US20120244122A1 (en) * 2009-05-28 2012-09-27 Masse Craig E Peptides for the Treatment of HCV Infections
CN102712644A (zh) * 2009-09-28 2012-10-03 豪夫迈·罗氏有限公司 丙肝病毒复制的新型大环抑制剂
US20150031768A1 (en) * 2011-08-19 2015-01-29 The Trustees Of Princeton University C-halogen bond formation
KR20230023817A (ko) 2013-12-03 2023-02-17 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법
CN106535898A (zh) * 2014-04-04 2017-03-22 细胞内治疗公司 有机化合物
EP3407889B1 (en) 2016-03-25 2021-05-19 Intra-Cellular Therapies, Inc. Organic compounds and their use in treating or preventing central nervous system disorders
JP7013454B2 (ja) 2016-10-12 2022-02-15 イントラ-セルラー・セラピーズ・インコーポレイテッド アモルファス固体分散体
CN116327770A (zh) 2017-03-24 2023-06-27 细胞内治疗公司 新组合物和方法
JP7457000B2 (ja) 2018-08-31 2024-03-27 イントラ-セルラー・セラピーズ・インコーポレイテッド 新規方法
KR20210052471A (ko) 2018-08-31 2021-05-10 인트라-셀룰라 써래피스, 인코퍼레이티드. 신규한 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10075033I2 (de) * 1993-11-30 2001-08-02 Searle & Co substituierte Pyrazolyl-benzolsulfonamide zur Behandlung von Entzündungen.
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
EP1104760B1 (en) * 1999-12-03 2003-03-12 Pfizer Products Inc. Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents

Also Published As

Publication number Publication date
PL370563A1 (en) 2005-05-30
IS7304A (is) 2004-06-10
EP1456179A1 (de) 2004-09-15
AU2002357973A1 (en) 2003-06-23
CN1612863A (zh) 2005-05-04
NO20042906L (no) 2004-07-09
DE10162121A1 (de) 2003-06-18
US20050222238A1 (en) 2005-10-06
WO2003050091A1 (de) 2003-06-19
CA2471743A1 (en) 2003-06-19
RU2004121033A (ru) 2006-01-10
JP2005516009A (ja) 2005-06-02
HUP0402422A2 (hu) 2005-03-29

Similar Documents

Publication Publication Date Title
IL162432A0 (en) Deuterated substituted pyrazolylbenzylsulfonamidesand medicaments comprising said compounds
GB0112834D0 (en) Medicaments
AU2002365120A8 (en) Medicaments
IL162406A0 (en) Deuterated substituted dihydrofuranones and medicaments containing these compounds
GB0101225D0 (en) Pharmaceutical compounds
GB0101227D0 (en) Pharmaceutical compounds
GB0128415D0 (en) Medicaments
GB0102902D0 (en) Medicaments
GB0105469D0 (en) Medicaments
AU2002342940A8 (en) New pharmaceutical compounds
HUP0402343A3 (en) Substituted beta-aminoalcohols used as medicaments
GB0115182D0 (en) Medicaments
GB0126997D0 (en) Medicinal Compounds
GB0127024D0 (en) Medicinal compounds
GB0122201D0 (en) Medicinal compounds
GB0105741D0 (en) Medicinal compounds
GB0105740D0 (en) Medicinal compounds
GB0125057D0 (en) Medicaments
GB0106875D0 (en) Medicaments
GB0125233D0 (en) Medicaments
GB0125056D0 (en) Medicaments
GB0124551D0 (en) Medicaments
GB0124538D0 (en) Medicaments
GB0124537D0 (en) Medicaments
GB0124161D0 (en) Medicaments